News | December 04, 2009

Image-Guidance Key to Minimally Invasive Oncology Procedures

Local bleeding as the result of an aneurysm rupture can now be visualized by syngo DynaCT in the angio lab. In addition, syngo DynaCT allows you to visualize the ventricular system of the brain to aid in diagnosing pathologic processes.

December 4, 2009 – The World Health Organization (WHO) predicts that cancer will become the world’s most frequent cause of death in 2010, replacing cardiovascular diseases as the most common cause of death. More than 10.6 million people are diagnosed with cancer each year. Of these, 1.3 million are afflicted with lung cancer, 1.2 million with breast cancer, and up to 1 million patients with colorectal tumors. The number of people suffering from cancer is expected to increase by another 50 percent by 2020 (source: WHO 2003).

New, minimally invasive procedures, suitable for the therapy of primary tumors and for metastases, have established themselves in recent years. The new procedures enable targeted tumor treatment via a catheter or a needle, while angiography systems display the position of the device in the patient’s body to the physician. Since therapy takes place locally, impact to the patient is minimalized and quality of life improved as he or she can be released from hospital soon afterward. These local procedures are especially recommended for older patients, who are in poor health, or have a medical condition that does not allow for a major operation or aggressive chemotherapy.

The interventional radiologist (IR) navigates catheters or needles in the millimeter range, using imaging systems and applications throughout the entire process, from tumor evaluation and procedure planning to therapy and follow-up.

To this end, Siemens Healthcare is demonstrating at RSNA 2009 annual conference held November 29-December 4, in Chicago, enhancements to the Artis zee platform, such as tools for improved planning, visualization, and needle guidance, designed to support interventional oncology procedures.

Display soft tissue, including tumors and of the complex structures of the blood vessels, is critical during therapy. syngo DynaCT shortens reconstruction times, enabling clinicians to take abdominal images available to the treating physician within 22 seconds. A study recently conducted at Charité Hospital in Berlin, Germany, showed that syngo DynaCT leads to repositioning of the catheter, and thus increases the reliability of the tumor treatment, in 50 percent of all chemoembolizations1.

A robotic-based angiography system, syngo DynaCT, offers the interventional radiologist greater flexibility and movement. The system’s flat detector rotates 220 degrees twice around the patient, providing cross-sectional images that can cover up to 47 cm. The liver and lungs can also be covered fully.

Advanced planning for embolization of tumor-feeding blood vessels can be done using the syngo Embolization Guidance program. The user can mark the vessel supplying the tumor, and automatically calculate the centerline of the vessel, which is then superimposed on the live fluoroscopic image, to simplify catheter guidance during tumor embolization.

Previously acquired CT, MR or PET/CT images can be fused with high-contrast 3D angiography images by using either the syngo InSpace 3D/3D Fusion solution, or with syngo DynaCT datasets. The fused dataset can be overlayed on live fluoroscopic images in the interventional lab and provides additional information on the tumor during the procedure.

If a tumor is to be treated with an ablative procedure, it is especially important to precisely position the needles that release the energy to the tumor. syngo iGuide helps to plan and position the needle. The iGuide Cappa navigation system supports the placement of radiofrequency and biopsy needles via electromagnetic navigation without requiring any radiation.

[1] Results of a study published in European Radiology March 2009 by Dr. Meyer, University of Berlin, Charite, Germany and Prof. Dr. Wacker; John Hopkins Hospital, Baltimore.

For more information: www.siemens.com/healthcare

Related Content

Video Plus Brochure Helps Patients Make Lung Cancer Scan Decision

Image courtesy of the American Thoracic Society

News | Lung Cancer | April 19, 2019
A short video describing the potential benefits and risks of low-dose computed tomography (CT) screening for lung...
HHS Extends Comment Period for Proposed Electronic Health Information Interoperability Rules
News | Electronic Medical Records (EMR) | April 19, 2019
The U.S. Department of Health and Human Services (HHS) is extending the public comment period by 30 days for two...
FDA Clears GE's Deep Learning Image Reconstruction Engine
Technology | Computed Tomography (CT) | April 19, 2019
GE Healthcare has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) of its Deep Learning Image...
In a demonstration on the exhibit floor of the SBI symposium, Koios software identified suspicious lesions in ultrasound images

In a demonstration on the exhibit floor of the SBI symposium, Koios software identified suspicious lesions in ultrasound images. Photo by Greg Freiherr

Feature | Artificial Intelligence | April 19, 2019 | By Greg Freiherr
Commercial efforts to develop...
Atrium Health Debuts Amazon Alexa Skill to Help Patients Access Medical Care
News | Artificial Intelligence | April 18, 2019
Atrium Health patients will now be able to use Amazon’s electronic voice system Alexa to not only locate the nearest...
Oxipit Introduces Multilingual Support for ChestEye AI Imaging Suite
News | Artificial Intelligence | April 16, 2019
The CE-certified ChestEye artificial intelligence (AI) imaging suite by Oxipit is now available in seven European...
iCAD Appoints Stacey Stevens as President
News | Radiology Business | April 16, 2019
iCAD Inc. recently announced that Stacey Stevens has been named president. As president, Stevens will have expanded...
Radiology Publishes Roadmap for AI in Medical Imaging
News | Artificial Intelligence | April 16, 2019
In August 2018, a workshop was held at the National Institutes of Health (NIH) in Bethesda, Md., to explore the future...